Concepedia

Olof Bengtsson

OB

Statistics

Publications

48

Citations

14.2K

H-Index

35

Active since

2007

Affiliations

Brigham and Women's Hospital(Current)

Universidad Nacional de Córdoba

Saint Luke's Hospital

Yale University

Rigshospitalet

Olof Bengtsson is an author at Brigham and Women's Hospital specializing in cardiovascular pharmacotherapy, heart failure, and pharmacology.

ORCID

Publications per year

2007–2023

48

Publications

48

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi et al. · New England Journal of Medicine · 2019 · 6.9K citations · Full text

, , +14

Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

Marc P. Bonaca, Deepak L. Bhatt, Marc Cohen et al. · New England Journal of Medicine · 2015 · 2K citations · Full text

, , +17

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

Mark C. Petrie, Subodh Verma, Kieran F. Docherty et al. · JAMA · 2020 · 536 citations · Full text

, , +17

A Trial to Evaluate the Effect of the Sodium–Glucose Co-Transporter 2 Inhibitor Dapagliflozin on Morbidity and Mortality in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction (DAPA-HF)

John J.V. McMurray, David L. DeMets, Silvio E. Inzucchi et al. · European Journal of Heart Failure · 2019 · 447 citations · Full text

, , +17

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis

Andreas Kindmark, A Jawaid, Chris Harbron et al. · The Pharmacogenomics Journal · 2007 · 368 citations

, , +17

1–5 of 48